GNH USA

Europe — EMA

Otrivin Comp (Xylometazoline Hydrochloride, Ipratropium Bromide)

Xylometazoline hydrochloride, the active ingredient in Otrivin Comp, is a nasal decongestant presented as a combination formulation for topical nasal use.

Request sourcing

1
Pack/s

What is Xylometazoline Hydrochloride, Ipratropium Bromide?

Xylometazoline hydrochloride, the active ingredient in Otrivin Comp, is a nasal decongestant presented as a combination formulation for topical nasal use. It relieves nasal congestion and reduces excess nasal secretions in adults and children. GNH USA supplies Otrivin Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Otrivin Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Xylometazoline Hydrochloride, Ipratropium Bromide used for?

Otrivin Comp combines Xylometazoline hydrochloride and Ipratropium bromide, acting on nasal passages to alleviate congestion and rhinorrhea.

- Common cold: Reduces nasal blockage and runny nose associated with viral upper respiratory infection. - Allergic rhinitis: Decreases nasal swelling and secretions caused by seasonal or perennial allergens. - Sinusitis: Improves nasal airflow and drainage in acute or chronic sinus inflammation. - Post‑operative nasal surgery recovery: Supports air‑flow and reduces crust of the nasal mucosa. - Nasal poly   -  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Xylometazoline Hydrochloride, Ipratropium Bromide
Route
Nasal Use
Manufacturer
Haleon Denmark Aps
Origin
EU

Related products